Evidence map›Paper›PMID 35201867›Full record

ArticleScience (New York, N.Y.)2022

Mechanism of signal sequence handover from NAC to SRP on ribosomes during ER-protein targeting.

Ahmad Jomaa, Martin Gamerdinger, Hao-Hsuan Hsieh, Annalena Wallisch, Viswanathan Chandrasekaran, Zeynel Ulusoy, Alain Scaiola, Ramanujan S Hegde, Shu-Ou Shan, Nenad Ban and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. TheProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Ahmad Jomaa *Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, 8093 Zurich, Switzerland.ORCID 0000-0002-5543-7942
Martin Gamerdinger *Department of Biology, Molecular Microbiology, University of Konstanz, 78457 Konstanz, Germany.ORCID 0000-0003-1483-8181
Hao-Hsuan Hsieh *Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0001-9629-5832
Annalena WallischDepartment of Biology, Molecular Microbiology, University of Konstanz, 78457 Konstanz, Germany.ORCID 0000-0002-4582-9619
Viswanathan ChandrasekaranMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0002-0871-4740
Zeynel UlusoyDepartment of Biology, Molecular Microbiology, University of Konstanz, 78457 Konstanz, Germany.ORCID 0000-0002-5476-3455
Alain ScaiolaDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, 8093 Zurich, Switzerland.ORCID 0000-0003-3233-3910
Ramanujan S HegdeMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0001-8338-852X
Shu-Ou ShanDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.ORCID 0000-0002-6526-1733
Nenad BanDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, 8093 Zurich, Switzerland.ORCID 0000-0002-9527-210X
Elke DeuerlingDepartment of Biology, Molecular Microbiology, University of Konstanz, 78457 Konstanz, Germany.ORCID 0000-0002-8905-0260
University of Konstanz · DEETH Zurich · CHCalifornia Institute of Technology · USMRC Laboratory of Molecular Biology · GB

Funding

Supplement: Accurate Molecular Decision Making during Protein BiogenesisR35GM136321 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Shu-ou Shan · 2020 to 2026
$6.7M
Medical Research Council MC_U105184332Medical Research Council MC_UP_A022_1007NIGMS NIH HHS R35 GM136321R35 GM136321Swiss National Science Foundation 141735Swiss National Science Foundation 163478Wellcome Trust
6 · The paper itself

Abstract

The nascent polypeptide-associated complex (NAC) interacts with newly synthesized proteins at the ribosomal tunnel exit and competes with the signal recognition particle (SRP) to prevent mistargeting of cytosolic and mitochondrial polypeptides to the endoplasmic reticulum (ER). How NAC antagonizes SRP and how this is overcome by ER targeting signals are unknown. Here, we found that NAC uses two domains with opposing effects to control SRP access. The core globular domain prevented SRP from binding to signal-less ribosomes, whereas a flexibly attached domain transiently captured SRP to permit scanning of nascent chains. The emergence of an ER-targeting signal destabilized NAC's globular domain and facilitated SRP access to the nascent chain. These findings elucidate how NAC hands over the signal sequence to SRP and imparts specificity of protein localization.

Indexed as

Protein Sorting SignalsAnimalsBinding SitesCaenorhabditis elegansCaenorhabditis elegans ProteinsEndoplasmic ReticulumHumansModels, MolecularMolecular ChaperonesProtein BindingProtein DomainsProtein TransportRibosomesSignal Recognition ParticleUbiquitinCaenorhabditis elegans ProteinsMolecular Chaperonesnascent-polypeptide-associated complexProtein Sorting SignalsSignal Recognition ParticleUbiquitin

Identifiers

PMID35201867
PMCPMC7612438
OpenAlexW4213437949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.